Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer
Creative Commons Attribution (CC-BY)
science
2022-10-21 00:00:00

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.


Open AccessArticle by
 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 1,5, 1, 1 and 1,* 


1
Department of Oncology and Metabolism, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK


2
Oncology and Clinical Research, University of Leeds, Leeds LS2 9JT, UK


3
Virttu Biologics Ltd., Biocity Scotland, Bo'Ness Rd, Newhouse ML1 5UH, UK


4
Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA


5
Sheffield ECMC, Cancer Clinical Trials Centre, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK


*
Author to whom correspondence should be addressed.
